GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVNEE) » Definitions » Other Stockholders Equity

Novartis AG (XSWX:NOVNEE) Other Stockholders Equity : CHF-0 Mil (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Other Stockholders Equity?

Novartis AG's Other Stockholders Equity for the quarter that ended in Sep. 2024 was CHF-0 Mil.

Novartis AG's quarterly Other Stockholders Equity declined from Mar. 2024 (CHF0 Mil) to Jun. 2024 (CHF0 Mil) and declined from Jun. 2024 (CHF0 Mil) to Sep. 2024 (CHF-0 Mil).

Novartis AG's annual Other Stockholders Equity stayed the same from Dec. 2021 (CHF0 Mil) to Dec. 2022 (CHF0 Mil) but then increased from Dec. 2022 (CHF0 Mil) to Dec. 2023 (CHF0 Mil).


Novartis AG Other Stockholders Equity Historical Data

The historical data trend for Novartis AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Stockholders Equity Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novartis AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Novartis AG Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Novartis AG's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines